Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

AIM WINNERS & LOSERS: Tiger Royalties to buy Bixby Technologies

20th Dec 2024 10:52

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.

----------

AIM - WINNERS

----------

Tiger Royalties & Investments PLC, up 50% at 0.15 pence, 12-month range 0.1p-0.275p. The natural resources sector-focused investor announces that on Thursday it signed a conditional agreement to acquire the entire issued share capital of Bixby Technology Inc from Toro Consulting Ltd, which is owned by Cykel AI PLC founder Jonathan Bixby, for GBP325,000. Tiger Royalties also has raised GBP3.0 million from 3.00 billion shares at 0.1p each. The fundraising comprises a placing of 2.48 billion shares at 0.1p each, and subscriptions for 525.0 million shares at the same price. Says Toro will also subscribe for new shares in Tiger Royalties worth GBP325,000 in total, at the fundraise price, and will receive one warrant per share. Fundraise participants and therefore new shareholders include Premier Miton Group PLC.

----------

Ascent Resources PLC, up 21% at 2p, 12-month range 1.47p-3.85p. The oil and gas explorer and producer has acquired a 49% interest in American Helium LLC's Utah and Colorado upstream acreage, including "direct interests in a proportionate share of 119,000 acres of helium-rich oil and gas licenses", for total consideration of USD2.0 million. Says this will consist of USD1.8 million in new Ascent shares at 5p each, plus around USD250,000 in cash. Also, Ascent intends to conduct a second distribution to shareholders with ring-fenced access to 41% of the net proceeds due from Ascent's damages claim against the Republic of Slovenia. Announces moreover that it has raised USD475,949 through issuing 7.5 million shares at 5p each, more than triple its closing price of 1.65p on Thursday.

----------

AIM - LOSERS

----------

Synairgen PLC, down 34% at 2.475p, 12-month range 2.475p-7.55p. Southampton, England-based drug discovery and biotechnology firm says it has conditionally raised GBP18.0 million through a subscription for 900.0 million new shares at 2p each by TFG Asset Management UK LLP "on behalf of the relevant funds". Adds that it intends to raise up to GBP6.0 million through subscriptions by "certain" directors for 1.3 million shares, and a placing and open offer for up to 298.8 million shares in total, in both cases also at 2p. Says it must raise a minimum of GBP2.9 million for the fundraise to proceed, with the maximum proceeds to be capped at GBP19 million. Says it will use the net proceeds to fund external and internal costs of a phase 2 trial of its investigational formula SNG001 in mechanically ventilated patients with confirmed respiratory viral infections.

----------

By Emma Curzon, Alliance News reporter

Comments and questions to [email protected]

Copyright 2024 Alliance News Ltd. All Rights Reserved.

FTSE 100 Latest
Value8,084.61
Change-20.71